JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 7 1200-1206
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, M. B.
Right arrow Articles by Morton, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, M. B.
Right arrow Articles by Morton, D. L.

Detection of Malignant Melanoma with Iodine-123 Iodoamphetamine

Marvin B. Cohen, Romaine E. Saxton, Ralph R. Lake, Leslie Cagle, L. Stephen Graham, Anne Nizze, Leslie S. Yamada, Manju Gan, Gabriella Bronca, Karen Greenwell and Donald L. Morton

Research Service and Nuclear Medicine Service, V.A. Medical Center, Sepulveda
Department of Surgery, University of California, Los Angeles, California

Correspondence: For reprints contact: Marvin B. Cohen, Nuclear Medicine Service, V.A. Medical Center, Sepulveda, CA 91343.

ABSTRACT

Iodoamphetamine (IMP) was shown by in vitro assay to have a high uptake by human melanotic melanoma cells, as compared to amelanotic melanoma cells. Eleven patients with proven malignant melanoma (MM) and 3 normal subjects were imaged at 2–4 hr and 16–24 hr after the i.v. injection 5 mCi (185 MBq) of [123I]IMP. One patient had a recurrent tumor that was subsequently shown to be squamous cell carcinoma. The index lesion was not visualized in the three patients with amelanotic melanomas. The index lesion/lesions were visualized in six of the seven other patients, except for 4/16 nodules in one patient. The seventh patient had a large, necrotic melanotic tumor that was not visualized, but an unsuspected lesion in the iliac nodes was detected. Multiple unsuspected lesions were detected in a second patient. While many lesions were seen at 2–4 hr, all lesions (other than a patient with small bowel disease) were seen best at 16–24 hr. No eye uptake was observed in any patient or control subject. Testicular uptake was seen in all males at 16–24 hr. Iodine-123 IMP appears to be a useful agent for the detection and follow-up of patients with melanotic MM.




This article has been cited by other articles:


Home page
JNMHome page
K. Kato, T. Kubota, M. Ikeda, M. Tadokoro, S. Abe, S. Nakano, M. Nishino, H. Kobayashi, and T. Ishigaki
Low Efficacy of 18F-FDG PET for Detection of Uveal Malignant Melanoma Compared with 123I-IMP SPECT
J. Nucl. Med., March 1, 2006; 47(3): 404 - 409.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.